Nulojix (belatacept): Extension of the temporary restriction in supply up until 4Q 2021 (initiated in March 2017)
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Nulojix
|
Active substance |
belatacept
|
Therapeutic area (MeSH) |
|
DHPC type |
Medicine shortage
|
Human ATC code |
L04AA28
|
Dissemination date |
23/09/2020
|